EP 2 187 879 B1 relates to a pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative, and is parent of two divisional applications, both deemed withdrawn.
Brief outline of the case
The opposition was rejected and all four opponents appealed.
The board decided revocation of the patent for lack of IS over D2=WO 2005/092 867 as CPA.